Clinical trial
Value of Ultra-fast Biparametric MRI in the Assessment of Prostate Cancer
NCT05903781 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Value of Ultra-fast Biparametric MRI in the Assessment of Prostate Cancer
- Lead sponsor
- University of Zurich
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 26, 2023
- Completion date
- February 18, 2025
- Enrollment
- 536 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer